Department of Physiology, AIIMS, New Delhi, 110029, India.
Department of Zoology, Govt. College for Girls, Sec-14, Gurugram, Haryana, 122001, India.
Adv Rheumatol. 2020 Jun 29;60(1):34. doi: 10.1186/s42358-020-00135-7.
OBJECTIVES: Fibromyalgia Syndrome (FMS), is a chronic pain disorder with poorly understood pathophysiology. In recent years, repetitive transcranial magnetic stimulation (rTMS) has been recommended for pain relief in various chronic pain disorders. The objective of the present research was to study the effect of low frequency rTMS over the right dorsolateral prefrontal cortex (DLPFC) on pain status in FMS. METHODS: Ninety diagnosed cases of FMS were randomized into Sham-rTMS and Real-rTMS groups. Real rTMS (1 Hz/1200 pulses/8 trains/90% resting motor threshold) was delivered over the right DLPFC for 5 consecutive days/week for 4 weeks. Pain was assessed by subjective and objective methods along with oxidative stress markers. Patients were followed up for 6 months (post-rTMS;15 days, 3 months and 6 months). RESULTS: In Real-rTMS group, average pain ratings and associated symptoms showed significant improvement post rTMS. The beneficial effects of rTMS lasted up to 6 months in the follow-up phase. In Sham-rTMS group, no significant change in pain ratings was observed. CONCLUSION: Right DLPFC rTMS can significantly reduce pain and associated symptoms of FMS probably through targeting spinal pain circuits and top-down pain modulation . TRIAL REGISTRATION: Ref No: CTRI/2013/12/004228.
目的:纤维肌痛综合征(FMS)是一种慢性疼痛障碍,其病理生理学尚不清楚。近年来,重复经颅磁刺激(rTMS)已被推荐用于治疗各种慢性疼痛障碍的疼痛。本研究的目的是研究低频 rTMS 对右侧背外侧前额叶皮质(DLPFC)的影响对 FMS 疼痛状况的影响。
方法:将 90 例确诊的 FMS 患者随机分为假刺激 rTMS(Sham-rTMS)和真实 rTMS(Real-rTMS)组。对 Real-rTMS 组(1Hz/1200 脉冲/8 个疗程/90%静息运动阈值)进行右 DLPFC 连续 5 天/周的治疗,共 4 周。通过主观和客观方法以及氧化应激标志物评估疼痛。患者在 rTMS 后进行 6 个月(rTMS 后 15 天、3 个月和 6 个月)的随访。
结果:在 Real-rTMS 组中,平均疼痛评分和相关症状在 rTMS 后显著改善。rTMS 的有益效果在随访阶段持续了 6 个月。在 Sham-rTMS 组中,疼痛评分没有明显变化。
结论:右侧 DLPFC rTMS 可显著减轻 FMS 的疼痛和相关症状,可能通过靶向脊髓疼痛回路和自上而下的疼痛调节。
试验注册号:Ref No:CTRI/2013/12/004228。
Front Pain Res (Lausanne). 2025-6-16
Mediterr J Rheumatol. 2025-3-31